Skip to main content
  • Home
  •  Overcoming the Challenges in Optimising GDMT in Heart Failure

Overcoming the Challenges in Optimising GDMT in Heart Failure

  • Heart Failure

Available Credit:

  • Not accredited

Course Published On:

Course Expiry Date:

Overcoming the Challenges in Optimising GDMT in HF
No ratings


Radcliffe Medical Education bring together a globally-renowned faculty, including Dr Gianluigi Savarese (Karolinska Institute, Stockholm, SE), Dr Stephen Greene (Duke University School of Medicine, North Carolina, US) and Prof Mark Petrie (University of Glasgow, Glasgow, UK) for a programme centred around the implementation of guideline-directed medical therapy (GDMT) in heart failure (HF).


During this session, presented, and recorded, at HFA 2023 in Prague, the panel discuss key aspects related to GDMT in heart failure including the importance of promptly initiating GDMT in heart failure patients and the challenges and barriers that exist in implementing GDMT in clinical practice. Further, they provide insights into effective strategies and approaches for overcoming barriers to GDMT initiation.


The programme also features short interactive video presentations and polls to provide you with practical knowledge and tools to implement GDMT effectively in your clinical practice.

Support Statement

This satellite symposium is supported by an unrestricted educational grant from AstraZeneca who had no involvement in the creation of the content.

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Primary Care Physicians
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Appraise the urgency needed in rapid initiation of GDMT to improve HF outcomes.
  • Recognise barriers preventing the use of GDMT in current practice.
  • Identify strategies needed to drive implementation of GDMT in clinical practice.
Register now Log in





Session 1 The Urgency to Implement GDMT 15 mins Gianluigi Savarese Stephen J Greene Mark Petrie
Session 2 Barriers to Achieving Optimal Medical Therapy 15 mins Gianluigi Savarese Stephen J Greene Mark Petrie
Session 3 Practical Strategies to Implement New Algorithms in GDMT 20 mins Gianluigi Savarese Stephen J Greene Mark Petrie
Audience Q&A Audience Q&A 10 mins Gianluigi Savarese Stephen J Greene Mark Petrie
Session 1.

The Urgency to Implement GDMT

Duration: 15 mins

Speakers: Gianluigi Savarese Stephen J Greene Mark Petrie

Session 2.

Barriers to Achieving Optimal Medical Therapy

Duration: 15 mins

Speakers: Gianluigi Savarese Stephen J Greene Mark Petrie

Session 3.

Practical Strategies to Implement New Algorithms in GDMT

Duration: 20 mins

Speakers: Gianluigi Savarese Stephen J Greene Mark Petrie

Audience Q&A.

Audience Q&A

Duration: 10 mins

Speakers: Gianluigi Savarese Stephen J Greene Mark Petrie


Gianluigi Savarese

Karolinska Institute, Stockholm, SE

Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden. 

View full profile


Stephen J Greene

Duke Clinical Research Institute, Duke University School of Medicine, North Carolina, US

Dr Greene is a cardiologist with a clinical and research interest in improving quality of care and outcomes for patients with heart failure.

View full profile

Mark Petrie

University of Glasgow, UK

Prof Mark Petrie is Professor of Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK. Prof Petrie started his studies as an undergraduate at Edinburgh University, before training in cardiology in Glasgow.

View full profile
This course is not accredited

Related Courses

A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure
  • Not accredited

Learning objectives

  • Recall guideline recommendations for the use of NT-proBNP in heart failure
  • Describe current practices in heart failure diagnosis and the impact on treatment outcomes
  • Develop an optimised approach to the timely diagnosis and management of heart failure
See more
An Expert Approach to Cardio-Renal Protection in CKD
  • 2.00 EBAC

Learning objectives

  • Recall clinical evidence and guidelines for the management of CKD patients without diabetes
  • Describe current gaps and barriers in evidence-based management for CKD without diabetes
  • Apply evidence based-management strategies to a case study
  • Use expert-led guidance to develop an optimal management approach to CKD patients without diabetes
See more
Implementing Heart Failure Guidelines with Collaborative Care
  • Not accredited

Learning objectives

  • Appraise new updates in heart failure guideline-directed medical therapy (GDMT)
  • Apply latest guideline recommendations to patient cases
  • Describe barriers preventing early initiation of GDMT
  • Identify the roles of nurses and other healthcare professionals to achieve optimal heart failure therapy
  • Identify the importance of the nurse/cross-functional team
See more
The Advancing Management of Transthyretin Amyloidosis
  • 1.00 EBAC

Learning objectives

  • To differentiate ATTR phenotypes based on presenting signs and symptoms.
  • To select appropriate tests to monitor symptomatic ATTR-cm from imaging, biomarker, functional and QoL assessments.
  • To recall how to identify disease progression across ATTR-cm.
  • To describe the different disease modifying treatments for ATTR including novel agents.
See more
Hyperkalaemia in Cardiorenal Disease – A Case Based Discussion
  • Not accredited

Learning objectives

  • Explain the relationship between sub-optimal RAASi therapy and poor cardio-renal outcomes
  • Identify patients who would benefit from anti-hyperkalaemia medications
  • Select appropriate anti-hyperkalaemia treatments across a range of patient profiles
  • Adopt anti-hyperkalaemia medications as an approach to prolong optimal RAASi therapy
  • Summarise current guideline recommendations on the use of potassium binding agents
See more
Examining a Complex Heart Failure Case
  • 1.00 EBAC

Learning objectives

  • Identify individuals likely to have HFpEF from initial presentation
  • Refer suspected individuals for specialist assessment
  • Initiate GDMT for HF as soon as patients are stable 
  • Initiate GDMT in HF regardless of EF and phenotype
  • Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists
See more
Obstructive Hypertrophic Cardiomyopathy: Getting It Right First Time
  • 1.00 EBAC

Learning objectives

  • Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
  • Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
  • Select appropriate imaging modalities to facilitate accurate risk stratification
  • Stratify patients based on specific risk features and disease severity
  • Choose suitable treatment modalities for patients based on specific disease features and severity
See more
Incorporating GDMT and PRO Endpoints for Personalised HF Management
  • 1.00 EBAC

Learning objectives

  • Review current GDMT in HFrEF and HFpEF
  • Describe the relationship between initiation of GDMT and HF outcomes
  • Prescribe GDMT according to current international recommendations
  • Recall the elements of the Kansas City Cardiomyopathy Questionnaire
  • Describe the clinical studies that support the use of functional and QoL measures in practice
  • Initiate quality of life and functional improvement measures in routine practice
  • Initiate SGLT-2 inhibitors in patients presenting with De novo HF and in patients already on other GDMT
  • Adopt shared decision-making with HF patients
See more
Changing Paradigms in Therapy to Unmet Needs
  • 1.00 EBAC

Learning objectives

  • Recall the utility of EF in heart failure treatment, patient selection and treatment response 
  • Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy 
  • Incorporate quality of life measures for assessing therapeutic efficacy in HF 
  • Recall outcomes from heart failure trials from recent congress and publications and their impact on practice 
See more
SGLT-2 Inhibitors - Another Piece of the Puzzle in Heart Failure
  • 1.00 EBAC

Learning objectives

  • Recall the results of key trials in HFmrEF in different patients' sub-groups
  • Describe how SGLT-2 inhibitors can be used across the range of LVEF
  • Apply emerging diagnostic approaches for HFpEF and HFmrEF
  • Implement best-practice strategies across the range of LVEF
See more